For example, the identification of MYCN amplification in spinal ependymoma or H3 K27M mutations in astrocytoma can guide clinicians toward more aggressive surveillance and treatment plans, even when traditional features suggest a low-grade lesion. Here, MYCN is linked to astrocytoma (excluding glioblastoma).